Filing Details
- Accession Number:
- 0001001250-20-000043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-18 16:54:24
- Reporting Period:
- 2020-05-18
- Accepted Time:
- 2020-05-18 16:54:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001250 | Estee Lauder Companies Inc | EL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 112408943 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1745075 | Jane Hudis Hertzmark | The Estee Lauder Companies Inc. 767 Fifth Avenue New York NY 10153 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2020-05-18 | 2,157 | $172.57 | 43,329 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2020-05-18 | 3,550 | $173.74 | 39,779 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2020-05-18 | 6,894 | $174.86 | 32,885 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $171.99 to $172.95 per share, inclusive.
- Sales prices range from $173.26 to $174.24 per share, inclusive.
- Sales prices range from $174.36 to $175.31 per share, inclusive.